Guillain-Barré Syndrome following ChAdOx1-S/nCoV-19 Vaccine
- PMID: 34114256
- DOI: 10.1002/ana.26143
Guillain-Barré Syndrome following ChAdOx1-S/nCoV-19 Vaccine
Abstract
As of April 22, 2021, around 1.5 million individuals in three districts of Kerala, India had been vaccinated with COVID-19 vaccines. Over 80% of these individuals (1.2 million) received the ChAdOx1-S/nCoV-19 vaccine. In this population, during this period of 4 weeks (mid-March to mid-April 2021), we observed seven cases of Guillain-Barre syndrome (GBS) that occurred within 2 weeks of the first dose of vaccination. All seven patients developed severe GBS. The frequency of GBS was 1.4- to 10-fold higher than that expected in this period for a population of this magnitude. In addition, the frequency of bilateral facial weakness, which typically occurs in <20% of GBS cases, suggests a pattern associated with the vaccination. While the benefits of vaccination substantially outweigh the risk of this relatively rare outcome (5.8 per million), clinicians should be alert to this possible adverse event, as six out of seven patients progressed to areflexic quadriplegia and required mechanical ventilatory support. ANN NEUROL 2021;90:312-314.
© 2021 American Neurological Association.
Comment in
-
Guillain-Barré Syndrome in an Australian State Using Both mRNA and Adenovirus-Vector SARS-CoV-2 Vaccines.Ann Neurol. 2021 Nov;90(5):856-858. doi: 10.1002/ana.26218. Epub 2021 Sep 28. Ann Neurol. 2021. PMID: 34528279 Free PMC article. No abstract available.
-
Adenovirus COVID-19 Vaccines and Guillain-Barré Syndrome with Facial Paralysis.Ann Neurol. 2022 Jan;91(1):162-163. doi: 10.1002/ana.26258. Epub 2021 Nov 12. Ann Neurol. 2022. PMID: 34699065 Free PMC article. No abstract available.
References
-
- COVID-19 Vaccination Status. Co-Win Statistics. Available at: cowin.gov.in. Accessed April 22, 2021.
-
- COVID-19 Vaccination Status. Available at: https://dashboard.kerala.gov.in/. Last accessed April 22, 2021.
-
- Greinacher A, Thiele T, Warkentin TE, et al. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med 2021;9:NEJMoa2104840.
-
- Waheed S, Bayas A, Hindi F, Rizvi Z, Espinosa PS. Neurological complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine. Cureus 2021;13:e13426.
-
- Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-245.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous